Healthcare Services

Advancements in early detection and non-invasive diagnostics are influencing the liver disease diagnostics market

April 23, 2026April 23, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Liver Disease Diagnostics Market Compare Between 2026 And 2030?

The liver disease diagnostics market has demonstrated robust growth in recent years. It is projected to increase from $38.95 billion in 2025 to $41.84 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. This historical growth can be attributed to factors such as the increasing prevalence of hepatitis infections, evolving alcohol consumption patterns, the early adoption of blood-based liver tests, a rising incidence of liver cirrhosis, and the expansion of hospital diagnostic infrastructure.

The liver disease diagnostics market is projected for significant expansion over the coming years. Its value is set to reach $55.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during the forecast period stems from factors such as the increasing prevalence of NAFLD and NASH, heightened understanding of preventive liver care, wider implementation of advanced imaging methods, the broadening of population health screening initiatives, and elevated healthcare expenditure on diagnostic services. Key developments expected during this period involve a heightened need for detecting liver disease early, increased reliance on non-invasive diagnostic approaches, more extensive screening for fatty liver and fibrosis, a wider scope for routine liver function tests, and an intensifying clinical focus on monitoring disease progression.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Which Important Drivers Are Guiding The Liver Disease Diagnostics Market Growth?

The projected rise in alcohol intake is set to fuel the growth of the liver disease diagnostics market moving forward. This increase in alcohol consumption is attributed to factors like evolving social norms, enhanced affordability, broad availability, and escalating stress or mental health issues. Liver disease diagnostics are essential for monitoring the impact of alcohol consumption on liver health, assisting in the early detection of liver damage signs such as fatty liver, hepatitis, or cirrhosis. For instance, in December 2024, according to the Bureau of Labor Statistics, a US-based government agency, in 2023, U.S. households spent an average of $294 on alcoholic beverages consumed at home and $343 on those consumed outside the home. Therefore, the upward trend in alcohol consumption is driving the expansion of the liver disease diagnostics market.

How Is The Liver Disease Diagnostics Market Segmented Across Different Segment Categories?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

4) By Other Diagnosis Techniques: Biomarker Testing, Fibrosis Scoring Systems

What Trends Are Influencing The Evolution Of The Liver Disease Diagnostics Market?

Companies at the forefront of the liver disease diagnostics market are concentrating on developing innovative solutions, such as non-invasive methods for liver assessment, to create more accurate and efficient diagnostic techniques. A non-invasive tool for liver assessment refers to diagnostic approaches that evaluate liver conditions using methods like elastography or blood tests, thus avoiding the need for invasive procedures like biopsies. For instance, in September 2024, City Imaging & Clinical, an India-based diagnostic center, launched FibroScan, a non-invasive diagnostic tool for liver assessment. Its aim is the early detection of liver diseases such as non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This advanced technology enables rapid and precise measurements of liver stiffness and fat content without requiring invasive procedures like biopsies. The process is quick, typically lasting 5 to 15 minutes, and involves placing a probe on the skin above the liver. The probe then emits sound waves, which measure liver tissue stiffness, aiding in the assessment of fibrosis or scarring.

Which Organizations Play A Role In The Liver Disease Diagnostics Market Landscape?

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, bioMérieux SA, Echosens SA, Hologic Inc., Canon Medical Systems Corporation, GE HealthCare Technologies Inc., Mindray Bio-Medical Electronics Co. Ltd., Samsung Medison Co. Ltd., Bruker Corporation, Sysmex Corporation, DiaSorin S.p.A., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., HEPQuant LLC, Aiforia Technologies Plc

Get The Full Liver Disease Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

Which Region Holds The Highest Market Share In The Liver Disease Diagnostics Market?

North America was the largest region in the liver disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Liver Disease Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

Browse Through More Reports Similar to the Global Liver Disease Diagnostics Market 2026, By The Business Research Company

Hepatitis Diagnostic Tests Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

Liver Diseases Therapeutics Market Report

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Clinical Diagnostics Market Report

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795